Abstract: Objective To introduce surveillance for medical product defects (MPD) in Taiwan area of China, and to offer references for drug safety surveillance in Mainland China. Methods Based on the related data with the author's learning experience in Taiwan area of China, MPD related issues such as the concept, risk categories, operating procedure, and surveillance Results were all introduced. Results The number of MPD reports continues to grow, the annual average number is more than 500 from 2004 to 2013 in Taiwan area of China, and the major defects of MPD are abnormal drug packaging and appearance. Conclusion Now MPD surveillance is an important part of drug safety surveillance, which plays more and more role in ensuring the safety of drug use as well as improving the quality of drug in Taiwan area of China.

Key words: medical product defects, surveillance, Taiwan area of China